Back to calendar
Tarsus Pharmaceuticals, Inc. (TARS) Earnings
TARS reports earnings on Tuesday, November 3, 2026
earnings report
November 3, 2026 · After Market Close
Q3 2026
Est. EPS: $-0.18
Actual EPS: $-14.40
EPS surprise: -886.84%
Company overview
Market Cap$3.4B
PriceUSD 69.07
EPS (TTM)-15.18
52-week high91.53
52-week low53.89
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees370